Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing –Remitting Multiple Sclerosis: STRIVE Data Analysis

ConclusionThese results highlight the effectiveness and safety of natalizumab in patients with early RRMS who self-identified as Black/AA or Hispanic/Latino.ClinicalTrials.govNCT01485003.

http://link.springer.com/10.1007/s40120-023-00461-0

Source: Neurology and Therapy - March 26, 2023 Category: Neurology Source Type: research